Department of Internal Medicine

References:
  • Nishiyama Y, Mitsuda Y, Taguchi H, Planque S, Salas M, Hanson CV, Paul S. Towards covalent vaccination: Improved polyclonal HIV neutralizing antibody response induced by an electrophilic gp120 V3 peptide analog. J Biol Chem. In press (Published online ahead of print; M706471200).
  • Nishiyama Y, Karle S, Planque S, Taguchi H, Paul S. Antibodies to the superantigenic site of HIV-1 gp120: Hydrolytic and binding activities of the light chain subunit. Mol Immunol. 2007 Apr;44(10):2707-18.
  • Nishiyama Y, Karle S, Mitsuda Y, Taguchi H, Planque S, Salas M, Hanson C, Paul S. Towards irreversible HIV inactivation: stable gp120 binding by nucleophilic antibodies. J Mol Recognit. 2006 Sep-Oct;19(5):423-31.
    4. Nishiyama Y, Mitsuda Y, Taguchi H, Planque S, Hara M, Karle S, Hanson CV, Uda T, Paul S.  Broadly distributed nucleophilic reactivity of proteins coordinated with specific ligand binding activity. J Mol Recognit. 2005 Jul-Aug;18(4):295-306.
  • Taguchi H, Keck Z, Foung SK, Paul S, Nishiyama Y. Antibody light chain-catalyzed hydrolysis of a hepatitis C virus peptide. Bioorg Med Chem Lett. 2004 Sep 6;14(17):4529-32.
  • Nishiyama Y, Bhatia G, Bangale Y, Planque S, Mitsuda Y, Taguchi H, Karle S, Paul S. Toward selective covalent inactivation of pathogenic antibodies: a phosphate diester analog of vasoactive intestinal peptide that inactivates catalytic autoantibodies. J Biol Chem. 2004 Feb 27;279(9):7877-83.